| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $253.48K | $429.31K | $427.05K | $528.06K | $527.64K |
| R&D | – | – | – | – | – |
| SG&A | $11.62K | $49.68K | $18.07K | $8.79K | $9.44K |
| Operating Income | – | – | – | -$528.06K | -$527.64K |
| Interest Expense | – | – | – | – | $350.00 |
| Tax Expense | – | – | – | – | – |
| Net Income | -$253.48K | -$393.51K | -$4.85M | -$528.06K | -$420.13K |
| EPS (basic) | -0.0100 | -0.0100 | -0.1000 | -0.0100 | – |
| EPS (diluted) | -0.0100 | -0.0100 | -0.1000 | -0.0100 | – |
| Shares (diluted) | $47.64M | $47.64M | $49.08M | $47.64M | – |